Skip to main content

Advertisement

Log in

Coronary Involvement in Infants with Kawasaki Disease Treated with Intravenous γ-Globulin

  • Original
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Aim

To analyze the clinical spectrum and the incidence of coronary involvement in infants with typical Kawasaki's disease (KD).

Patients and Methods

A retrospective study was performed on children one year of age or younger diagnosed from February 1992 to January 2006 with typical KD. Children with incomplete forms of the disease were not included.

Results

Twenty-five infants were diagnosed with KD during the study period. The median age of the patients was 10 months (range, 4–12 months). All children but one received intravenous gammaglobulin (IVIG), 84% before the 10th day of disease. Seven patients (28%) required the administration of more than one dose of IVIG, because persistence of fever. Coronary artery disease (CAD) was recorded in 6 cases (24%), five of them being boys. All patients with CAD were treated with ASA plus IVIG and 84% of them received this therapy within the first 10 days of the KD onset.

Conclusions

In spite of the exclusion of our study of incomplete presentations and of an early administration of IVIG in our patients, we have observed a high rate of infants who developed CAD, which is similar to the one reported in children who do not receive IVIG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB (2006) Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis J 25:245–259

    Article  PubMed  Google Scholar 

  2. Centers for Disease Control and Prevention. National Center for Infectious Diseases, Atlanta, GA. Available at: http://www.cdc.gov/ncidod/diseases/kawasaki/index.htm. Accessed: November 17, 2006

  3. Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH (2006) Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 25:241–244

    Article  PubMed  Google Scholar 

  4. Chang RR (2002) Hospitalizations for Kawasaki disease among children in the United States,1988–1997. Pediatrics 109:E87

    Article  PubMed  Google Scholar 

  5. Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY (2006) Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 39:387–391

    PubMed  Google Scholar 

  6. Durongpisitkul K, Gurujai VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurism in Kawasaki disease: a meta analysis of the efficacy of aspirin and inmunoglobulin treatment. Pediatrics 96:1057–1061

    PubMed  CAS  Google Scholar 

  7. Kato H, Sugimura T, Akagi T, et al. (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385

    PubMed  CAS  Google Scholar 

  8. Martínez Ruiz M, del Castillo Martín F, Borque Andrés C, et al. (2003) Incidencia y características clínicas de la enfermedad de Kawasaki en nuestro medio. An Pediatr (Barc) 59:323–327

    Article  Google Scholar 

  9. Nakamura Y, Fujita Y, Nagai M, et al. (1991) Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics 88:1144–1147

    PubMed  CAS  Google Scholar 

  10. Newburger JW, Takahashi M, Gerber MA, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733

    Article  PubMed  Google Scholar 

  11. Nomura Y, Yoshinaga M, Masuda K, Takei S, Miyata K (2002) Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J Infect Dis 185:1677–1680

    Article  PubMed  CAS  Google Scholar 

  12. Onouchi Z, Kawasaki T (1999) Overview of pharmacological treatment of Kawasaki disease. Drugs 58:813–822

    Article  PubMed  CAS  Google Scholar 

  13. Rosenfeld EA, Corydon KE, Shulman ST (1995) Kawasaki disease in infants less than one year of age. J Pediatr 126:524–529

    Article  PubMed  CAS  Google Scholar 

  14. Rowley AH, Shulman ST (1998) Kawasaki syndrome. Clin Microbiol Rev 11:405–414

    PubMed  CAS  Google Scholar 

  15. Seve P, Stankovic K, Samil A, Durand DV, Marchand G, Broussolle C (2005) Adult Kawasaki disease: report of two cases and literature review. Semin Arth Rheum 34:785–792

    Article  Google Scholar 

  16. Shulman ST, De Inocencio J, Hirsch R (1995) Kawasaki disease. Pediatr Clin North Am 42:1205–1222

    PubMed  CAS  Google Scholar 

  17. Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG (1987) Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 141:420–425

    PubMed  CAS  Google Scholar 

  18. Chang RR (2002) Hospitalizations for Kawasaki disease among children in the United States,1988–1997. Pediatrics 109:E87

    Article  PubMed  Google Scholar 

  19. Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY (2006) Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 39:387–391

    PubMed  Google Scholar 

  20. Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–389

    PubMed  CAS  Google Scholar 

  21. Tseng CF, Fu YC, Fu LS, Betau H, Chi CS (2001) Clinical spectrum of Kawasaki disease in infants. Zhonghua Yi Xue Za Zhi (Taipen) 64:168–173

    CAS  Google Scholar 

  22. Yanagawa H, Nakamura Y, Yashiro M, et al. (2001) Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 107:E33

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Méndez-Echevarría.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno, N., Méndez-Echevarría, A., de Inocencio, J. et al. Coronary Involvement in Infants with Kawasaki Disease Treated with Intravenous γ-Globulin. Pediatr Cardiol 29, 31–35 (2008). https://doi.org/10.1007/s00246-007-9068-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-007-9068-0

Keywords

Navigation